Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment

Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment

H7N9 viruses quickly spread between mammalian hosts and carry the risk of human-to-human transmission, as shown by the 2013 outbreak. Acute respiratory distress syndrome (ARDS), lung failure, and acute pneumonia are major lung diseases in H7N9 patients. Transplantation of mesenchymal stem cells (MSC...

Full description

Bibliographic Details
Main Authors: Jiajia Chen, Chenxia Hu, Lijun Chen, Lingling Tang, Yixin Zhu, Xiaowei Xu, Lu Chen, Hainv Gao, Xiaoqing Lu, Liang Yu, Xiahong Dai, Charlie Xiang, Lanjuan Li
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Engineering
Subjects:
H7N9
Mesenchymal stem cell
Epidemic Influenza A
Acute respiratory distress syndrome
COVID-19
Stem cell therapeutics
Online Access:http://www.sciencedirect.com/science/article/pii/S2095809920300370

Internet

http://www.sciencedirect.com/science/article/pii/S2095809920300370

Similar Items